Preclinical

Blockchain could accelerate drug development: Bloqcube

15-Feb-2021 By Jenni Spinner

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

AHA training aids researchers with heart-to-heart talks

14-Feb-2021 By Jenni Spinner

The American Heart Association’s Heart of Communicating Science modules are designed to help experts break complex talk into easy-to-understand language.

Immunity-centric biotech firm lands $60m in Series A funding

11-Feb-2021 By Jenni Spinner

Immunai has secured a total of $80m in funding to develop and promote its efforts to harness machine learning to fuel advancement of novel immunotherapies.

Sanofi, MIT Jameel Clinic join to advance health research with AI

09-Feb-2021 By Jenni Spinner

The collaboration between the Jameel Clinic and pharma firm will harness artificial intelligence and machine learning in developing health solutions.

CELLINK launches all-in-one imager, single-cell dispenser

09-Feb-2021 By Jenni Spinner

The UP.SIGHT single-sell dispensing system is designed to boost efficiency in cell-line development workflows and offer double assurance of clonality.

World Cancer Day

Super Bowl player donates to help fund cancer research

04-Feb-2021 By Jenni Spinner

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

COVID-19 tools from Cerba aim to save researchers time

28-Jan-2021 By Jenni Spinner

The company has released two products designed to help clinical researchers accelerate development of treatments and vaccines for the COVID-19 virus.

Paradigm4, 54gene collaborate on African clinical data

26-Jan-2021 By Jenni Spinner

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

Widening access to COVID-19 data

18-Jan-2021 By Rachel Arthur

California information technology and services company Syntegra and the National Institutes of Health (NIH) have signed a partnership to 'democratize access to the largest set of COVID-19 patient records': with the use of Syntegra's synthetic...

AI-driven drug discovery collaboration to tackle neurological diseases

12-Jan-2021 By Jenni Spinner

Sosei Heptares and PharmEnable will harness artificial intelligence-enabled technology and advanced chemistry to explore neurological disease solutions.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Lexaria broadens COVID-19 drug exploration program

11-Jan-2021 By Jenni Spinner

The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.

Phesi, Sensyne Health partner on synthetic arm tech for trials

07-Jan-2021 By Jenni Spinner

The two organizations will collaborate on development of synthetic arms for clinical studies, drawing from millions of patient records and trial subject.

Pediatric trial challenges highlighted in patient survey

04-Jan-2021 By Jenni Spinner

Conducted via a partnership between Parexel and CISCRP, the study reveals insights about the needs and concerns of pediatric patients and their families.

Clinical informatics company raises $21.5m to fund tech

23-Dec-2020 By Jenni Spinner

Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.

‘Explosion’ of health data fuels pharma advances: Linguamatics

22-Dec-2020 By Jenni Spinner

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.

Collaboration to chart AI-generated map of the immune system

21-Dec-2020 By Jenni Spinner

A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.

Sanofi joins Aqemia to develop COVID-19 treatments

21-Dec-2020 By Jenni Spinner

The pharma firm will lend support to Aqemia’s high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.

Biomarkers pave the way to personalized care: Quanterix

21-Dec-2020 By Jenni Spinner

An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.

Chicago life-sciences incubator to open in early 2021

14-Dec-2020 By Jenni Spinner

The resource—designed to provide seed capital, lab space, offices and management consulting to researchers—is opening its doors earlier than expected.

CROs partner on women’s oncology clinical solutions

10-Dec-2020 By Jenni Spinner

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for women’s cancers.

Current FDA COVID-19 developments

09-Dec-2020 By Jenni Spinner

The agency continues to offer advice, resources and oversight during the pandemic to help develop tests, treatments and other solutions for the virus.

Eversana, ArisGlobal team up on drug-safety automation

08-Dec-2020 By Jenni Spinner

The two companies plan to work together on technology that advances pharmacovigilance in order to increase safety and effectiveness of new therapies.

Webinar takes in-depth look at the future of clinical research

07-Dec-2020 By Jenni Spinner

OSP's free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.

Ancestry study explores COVID-19 genetic risks

07-Dec-2020 By Jenni Spinner

The online DNA network has delved into self-reported data of more than 563,000 US adults to help identify genetic risk of infection and severe outcomes.

COVID-19 collaboration to study patient risk via blood

01-Dec-2020 By Jenni Spinner

Health tech specialists GoodCell are working with the New York Blood Center to identify COVID-19 patients with elevated risk of adverse clinical outcomes.

Janssen partners with Koa Health on digital depression treatments

30-Nov-2020 By Jenni Spinner

The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.

Collaboration harnesses AI to fight COVID-19 in hot zones

24-Nov-2020 By Jenni Spinner

Berg will work with healthcare professionals at AdventHealth to track COVID-19 in targeted areas and use resulting data to improve patient outcomes.

Novartis, Elsevier collaborate on risk-assessment tool

12-Nov-2020 By Jenni Spinner

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

AI speeds adapting to post-COVID ‘new normal’: WhizAI

12-Nov-2020 By Jenni Spinner

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

Metabolic-disease CRO poised for growth

02-Nov-2020 By Jenni Spinner

With an infusion of capital from investors 1315 Capital, ProSciento is setting its sights on expansion of its specialized clinical research services.

Global Genes forges rare-disease support network partnership

22-Oct-2020 By Jenni Spinner

The rare-disease organization will work with Rady Children’s Institute for Genomic Medicine to help patients and their families connect with solutions

WuXi AppTec: think ahead when dual-filing IND applications

20-Oct-2020 By Jenni Spinner

A leader from the company advises planning ahead when filing investigational new drug applications to avoid wasting time, work and money later.

ACD/Labs analytical platforms upgraded for COVID-19 age

15-Oct-2020 By Jenni Spinner

The company's Spectus and Percepta platforms offer features to help researchers meet challenges associated with working and collaborating in the pandemic.

CPhI Festival of Pharma

CPhI, Pharmapack Europe to return in 2021

08-Oct-2020 By Jenni Spinner

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

People on the Move: October 2020

07-Oct-2020 By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

Premier Research: holistic approach benefits drug development

06-Oct-2020 By Jenni Spinner

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

SciBite introduces insight-building AI software

24-Sep-2020 By Jenni Spinner

The AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.

Thermo Fisher to collaborate on biomarker discovery project

22-Sep-2020 By Jenni Spinner

Thermo Fisher Scientific will partner with AstraZeneca and the University of Nebraska Medical Center to advance biomarker discovery and characterization.

Parexel, Pfizer extend drug development partnership

22-Sep-2020 By Jenni Spinner

The drug discovery and pharma companies have extended their agreement to collaborate on development of new treatments for a range of therapeutic areas.

AI presents obstacles and opportunities in pharma: Iqvia

16-Sep-2020 By Jenni Spinner

A leader from Iqvia will present an overview of artificial intelligence, machine learning and other \technology during this year’s CPhI Festival of Pharma.

Medidata shifts its Commercial Data Solutions unit

15-Sep-2020 By Jenni Spinner

Acquired in 2018, the data analytics provider formerly known as Shyft Analytics will now be part of the company’s Acorn by AI unit.

Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations

14-Sep-2020 By Rachel Arthur

Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Genetics’ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).

Europital expands UK clinical research presence

10-Sep-2020 By Jenni Spinner

The clinical research service provider is opening a new CRO site in the UK to meet growing demand from biotech industry clients.

Inspire introduces program to foster research collaboration

09-Sep-2020 By Jenni Spinner

The Inspire Research Accelerator is designed to let academic researchers anywhere in the world to collaborate with the company.

IntelGenx, ATAI partner on film-based psychedelics

03-Sep-2020 By Jenni Spinner

The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

COVID-19 treatment study predicts adverse drug events

03-Sep-2020 By Jenni Spinner

Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.

COVID-19 report shares insights on potential therapies

01-Sep-2020 By Jenni Spinner

A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.

AstraZeneca, World Heart Federation partner on CV solutions

01-Sep-2020 By Jenni Spinner

The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.

NIAID awards $44m contract to advance COVID-19 drug

31-Aug-2020 By Jenni Spinner

The US institute has given a new contract to drug developer BioCryst to explore use of galidesivir in treatment of non-hospitalized COVID-19 patients.